Reproductive Medicine and Infertility Associates

Reproductive Medicine and Infertility Associates (RMIA) operates under several aliases, including RMI Associates and RMI Infertility Associates. The organization is an infertility clinic that provides reproductive medicine services to individuals and couples experiencing difficulty conceiving. Its core activities include diagnostic evaluations, fertility treatment planning, and coordination of assisted reproductive technology procedures. In addition to patient care, RMIA manages donor gamete services, involving the collection, storage, and use of donor sperm and eggs. This specialization in both patient treatment and donor coordination distinguishes the clinic from general obstetrics and gynecology practices. The clinic’s headquarters is situated in the United States of America, with the known security incident indicating an operational presence in Minnesota. As a provider of reproductive health services, RMIA routinely handles sensitive personal and health information for both patients and gamete donors.

On December 5, 2018, the clinic reported a malware intrusion that compromised names, addresses, dates of birth, health insurance details, treatment records, and Social Security numbers specifically for donors. Upon detecting the unauthorized access, RMIA engaged external forensic experts to remove the malicious software and to investigate whether any data had been viewed or exfiltrated. The forensic investigation concluded that there was no evidence of actual or attempted misuse of the exposed information. The organization communicated this finding to stakeholders, emphasizing that the breach appeared to be contained without subsequent exploitation. This incident highlights the cybersecurity challenges faced by healthcare entities that store extensive personal identifiers, particularly those involved in reproductive medicine and donor programs. While the clinic’s exact size, patient volume, or ownership structure is not disclosed in the available sources, it continues to operate as a dedicated infertility practice. The aliases used by the organization reflect its branding across different service lines and referral networks. No further details about parent‑company relationships, subsidiaries, or changes in ownership subsequent to the 2018 event are provided in the referenced material. Consequently, any description of RMIA’s scale or corporate affiliations must rely solely on the explicit facts presented here.